| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $5.2M | $7.8M | $6.1M |
| YoY Revenue Growth % | -32.6% | +26.7% | — |
| Gross Profit | $2.6M | $4.3M | — |
| Gross Margin % | 48.7% | 55.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$32.4M | -$26.9M | -$121.0M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | $10.0M | -$72.6M | -$115.6M |
| EBITDA (Normalized) | -$31.8M | -$26.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$27.6M | -$22.6M | -$76.6M |
| Capital Expenditures (CapEx) | $713.0K | $265.0K | — |
| Free Cash Flow (FCF) | -$28.4M | -$22.9M | -$76.6M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $18.2M | $31.2M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $74.7M | -$9.5M | — |